Table 4 Prevalence of metabolic syndrome in Iran based on IDF criteria

IDF

Overall

60

31% (28 − 34%)

99.68%

< 0.001

-1.10

0.996

0.2707

Sex

Female

37

36% (30 − 42%)

99.66%

< 0.001

-1.75

1.325

0.1855

Male

40

25% (22 − 28%)

99.24%

< 0.001

-1.06

0.879

0.2268

Age

< 18

4

4% (2 − 7%)

96.81%

< 0.001

-1.10

0.996

0.2707

18–30

1

12% (8 − 17%)

 -

 -

30–65

48

35% (32 − 38%)

99.47%

< 0.001

> 65

1

42% (38 − 46%)

 -

 -

Health Status

Healthy/not reported

55

29% (26 − 33%)

99.69%

< 0.001

-1.10

0.996

0.2707

Diabetes Mellitus

2

79% (77 − 82%)

 -

 -

Other Diseases

3

30% (13 − 51%)

 -

 -

Province

Khorasan

7

41% (36 − 47%)

99.18%

< 0.001

-1.10

0.996

0.2707

Tehran

11

33% (23 − 44%)

99.57%

< 0.001

Yazd

2

20% (17 − 22%)

 -

 -

Kermanshah

1

42% (41 − 43%)

 -

 -

Qazvin

2

25% (23 − 27%)

 -

 -

Golestan

2

25% (24 − 27%)

 -

 -

Ardabil

1

21% (17 − 25%)

 -

 -

Hormozgan

3

26% (19 − 34%)

 -

 -

Guilan

1

43% (42 − 44%)

 -

 -

Qom

1

73% (67 − 79%)

 -

 -

Mazandaran

4

29% (24 − 34%)

95.20%

 -

Fars

7

35% (22 − 48%)

99.83%

 -

West Azerbaijan

3

31% (28 − 34%)

 -

 -

Kerman

3

35% (30 − 41%)

 -

 -

Semnan

3

28% (20 -36%)

 -

 -

Sistan and Baluchestan

2

19% (18 − 21%)

 -

 -

multi province

7

24% (10 − 40%)

99.92%

 -

Components

W_C

28

58% (52 − 64%)

99.77%

< 0.001

-1.51

1.920

0.4315

IFG

27

31% (26 − 36%)

99.69%

< 0.001

-0.51

1.704

0.7655

TG

27

38% (34- 42%)

99.46%

< 0.001

-0.87

1.240

0.4829

HDL

27

54% (49 − 59%)

99.67%

< 0.001

0.14

1.387

0.9220

BP

24

33% (29 − 38%)

99.53%

< 0.001

-2.34

1.871

0.2117